NCT01997983View on ClinicalTrials.gov

Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

August 31, 2015

Conditions
Interstitial CystitisIC
Interventions
DEVICE

TC-3 Gel mixed with Botox (BTX)

TC-3 gel mixed with Botox (BTX). Single intravesical instillations of 40 ml of TC-3 mixed with 200 units of preconstitued BTX, using catheter

Trial Locations (1)

Unknown

Assaf Harofeh Medical Center, Ẕerifin

All Listed Sponsors
lead

UroGen Pharma Ltd.

INDUSTRY

NCT01997983 - Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients | Biotech Hunter | Biotech Hunter